PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'School of Food and Bioengineering, Shaanxi University of Science & Technology, Xi\'an, 710021, PR China. Electronic address: chengyuanliang@gmail.com.\', \'School of Food and Bioengineering, Shaanxi University of Science & Technology, Xi\'an, 710021, PR China.\', \'Department of Urology Surgery Center, The People\'s Hospital of Xinjiang Uyghur Autonomous Region, Urumqi, 830002, PR China.\', \'Xi\'an Taikomed Pharmaceutical Technology Co., Ltd., Xi\'an, 710077, PR China.\', \'Shaanxi Panlong Pharmaceutical Group Co., Ltd., Xi\'an, 710025, PR China.\', \'Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, 200040, PR China. Electronic address: zhaoxush@163.com.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0223-5234(20)30499-210.1016/j.ejmech.2020.112527
?:doi
?:hasPublicationType
?:journal
  • European journal of medicinal chemistry
is ?:pmid of
?:pmid
?:pmid
  • 32563812
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.266
?:rankingScore_hIndex
  • 127
?:title
  • A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32563812>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32563812>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all